Jeremy B. Hayden - Net Worth and Insider Trading
Jeremy B. Hayden Net Worth
The estimated net worth of Jeremy B. Hayden is at least $942,591 dollars as of 2024-05-02. Jeremy B. Hayden is the Chief Legal Officer of Sight Sciences Inc and owns about 168,620 shares of Sight Sciences Inc (SGHT) stock worth over $942,586. Jeremy B. Hayden is also the General Counsel & VP of BD of Plus Therapeutics Inc and owns about 3 shares of Plus Therapeutics Inc (PSTV) stock worth over $5. Details can be seen in Jeremy B. Hayden's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeremy B. Hayden has not made any transactions after 2024-04-03 and currently still holds the listed stock(s).
Transaction Summary of Jeremy B. Hayden
Jeremy B. Hayden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy B. Hayden owns 3 companies in total, including Endologix Inc (ELGXQ) , Plus Therapeutics Inc (PSTV) , and Sight Sciences Inc (SGHT) .
Click here to see the complete history of Jeremy B. Hayden’s form 4 insider trades.
Insider Ownership Summary of Jeremy B. Hayden
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELGXQ | Endologix Inc | 2019-10-03 | General Counsel |
| PSTV | Plus Therapeutics Inc | 2015-09-02 | General Counsel & VP of BD |
| SGHT | Sight Sciences Inc | 2024-04-03 | Chief Legal Officer |
Jeremy B. Hayden Latest Holdings Summary
Jeremy B. Hayden currently owns a total of 2 stocks. Among these stocks, Jeremy B. Hayden owns 168,620 shares of Sight Sciences Inc (SGHT) as of April 3, 2024, with a value of $942,586 and a weighting of 100%. Jeremy B. Hayden also owns 3 shares of Plus Therapeutics Inc (PSTV) as of September 2, 2015, with a value of $5 and a weighting of 0%.
Latest Holdings of Jeremy B. Hayden
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGHT | Sight Sciences Inc | 2024-04-03 | 168,620 | 5.59 | 942,586 |
| PSTV | Plus Therapeutics Inc | 2015-09-02 | 3 | 1.72 | 5 |
Holding Weightings of Jeremy B. Hayden
Jeremy B. Hayden Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy B. Hayden has made a total of 2 transactions in Sight Sciences Inc (SGHT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sight Sciences Inc is the sale of 4,893 shares on April 3, 2024, which brought Jeremy B. Hayden around $24,856.
According to the SEC Form 4 filings, Jeremy B. Hayden has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 1 shares on September 2, 2015, which cost Jeremy B. Hayden around $2,952.
Insider Trading History of Jeremy B. Hayden
- 1
Jeremy B. Hayden Trading Performance
GuruFocus tracks the stock performance after each of Jeremy B. Hayden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeremy B. Hayden is -5.31%. GuruFocus also compares Jeremy B. Hayden's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeremy B. Hayden within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeremy B. Hayden's insider trading performs compared to the benchmark.
Performance of Jeremy B. Hayden
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.44 | | | | | |
| Relative Return to S&P 500(%) | 4.3 | | | | | |
Jeremy B. Hayden Ownership Network
Jeremy B. Hayden Owned Company Details
What does Endologix Inc do?
Who are the key executives at Endologix Inc?
Jeremy B. Hayden is the General Counsel of Endologix Inc. Other key executives at Endologix Inc include director & CEO and Director John Onopchenko , Chief Medical Officer Matthew Thompson , and Controller and Corp Secretary Timothy Nicholas Brady .
Endologix Inc (ELGXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Endologix Inc (ELGXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endologix Inc (ELGXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Endologix Inc (ELGXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Endologix Inc Insider Transactions
Jeremy B. Hayden Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy B. Hayden. You might contact Jeremy B. Hayden via mailing address: 2 Musick, 2 Musick, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
